FIELD: measurement; testing.
SUBSTANCE: invention relates to a method for diagnosing a respiratory infection associated with a bacterial infection; a method for selecting patients with respiratory infection for administration of an antibiotic; a method for determining time to stop the administration of an antibiotic to a patient with a respiratory infection receiving an antibiotic; a method of selecting patients among patients with respiratory infection taking an antibiotic for whom antibiotic administration will be ceased.
EFFECT: invention provides a method for treating a respiratory infection associated with a bacterial infection, based on identification of the level of sCD14-ST in urine used as an indicator, with respect to a threshold value of 3338-5758 pg/ml.
19 cl, 1 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSIS OF RESPIRATORY TRACT INFECTIOUS DISEASE USING BLOOD SAMPLES | 2012 |
|
RU2660352C2 |
| DIAGNOSING INFECTIOUS AIRWAY DISEASE USING BLOOD SAMPLES | 2012 |
|
RU2723554C2 |
| SPECIFICALLY PURIFIED ANTIBODIES AGAINST PRESEPSIN | 2015 |
|
RU2739607C2 |
| PRO-CALCITONIN FOR DIAGNOSIS OF BACTERIAL INFECTIONS AND CONTROL OF ANTIBIOTIC TREATMENT FOR PATIENTS WITH NONSPECIFIC COMPLAINTS | 2011 |
|
RU2580278C2 |
| BIOMARKERS FOR TUBERCULOSIS | 2014 |
|
RU2697549C2 |
| PROADM FOR PREDICTING RISK OF CONDITION REQUIRING HOSPITALIZATION IN PATIENTS WITH SYMPTOMS OF INFECTIOUS DISEASE | 2019 |
|
RU2820944C2 |
| METHOD FOR THE TREATMENT AND PREVENTION OF RECURRENCE OF NOSOCOMIAL PNEUMONIA | 2021 |
|
RU2794585C2 |
| HISTONES AND/OR proADM AS MARKERS INDICATING ADVERSE EVENT | 2017 |
|
RU2765212C2 |
| INHALED HEXAPEPTIDE FOR TREATING RESPIRATORY DISEASES ASSOCIATED WITH INTERLEUKIN-6 | 2020 |
|
RU2737799C1 |
| METHOD FOR EXPRESS ANALYSIS IN VITRO OF ANTIBIOTIC SENSITIVITY OF BACTERIA AND FUNGI IN PATIENT | 2020 |
|
RU2735983C1 |
